Chronic News and Research

RSS

Innate lymphoid cells may be new therapeutic target in treating atopic dermatitis

The increasing incidence of allergic skin diseases, and the accompanying economic burden and heightened risk of developing other allergic conditions, have spurred researchers to look for better ways to control these immune system-based disorders.

1 Feb 2013

Merck full-year 2012 worldwide sales decrease 2% to $47.3 billion

Merck, known as MSD outside the United States and Canada, today announced financial results for the fourth quarter and full year of 2012.

1 Feb 2013

Resonance Health receives FDA marketing authorization for FerriScan R2-MRI device

The U.S. Food and Drug Administration recently announced the authorization of FerriScan R2-MRI to be marketed as an imaging companion diagnostic device for the safe and effective use of Exjade in patients with non-transfusion-dependent thalassemia.

31 Jan 2013

Adults should consume less than 5 g of salt and at least 3,510 mg of potassium per day: WHO

Adults should consume less than 2,000 mg of sodium, or 5 grams of salt, and at least 3,510 mg of potassium per day, according to new guidelines issued by the WHO. A person with either elevated sodium levels and low potassium levels could be at risk of raised blood pressure which increases the risk of heart disease and stroke.

31 Jan 2013

Hypertensive pregnancies need rigorous follow up

Women who have hypertensive complications during pregnancy are at increased risk for developing chronic kidney disease and end-stage renal disease, shows a study in the Canadian Medical Association Journal.

31 Jan 2013

New insight into eczema’s itch

Research shows that innate lymphoid cells accumulate in active eczema lesions and may contribute to disease progression.

31 Jan 2013

Interferon retreatment of chronic hepatitis C may be harmful

People with hepatitis C and chronic liver disease who relapsed or failed to respond to initial treatment are unlikely to improve on interferon retreatment. In fact, they may face an increased risk of dying sooner, and are likely to experience a variety of adverse effects, according to an updated systematic review published in The Cochrane Library.

31 Jan 2013

State roundup: Ga. hospital fee bill nears passage

After a series of friendly questions and statements of support, the fast-tracked legislation on a state hospital provider fee swept through a House committee Tuesday. The House Government Affairs Committee, by a 15-1 vote, approved Senate Bill 24, which would facilitate the renewal of the assessment. The state Senate passed the bill earlier this month. The legislation could reach the House floor Thursday or Friday. If it passes, it then would go to Gov. Nathan Deal for his signature -- an unusually rapid journey into law.

31 Jan 2013

World Health Assembly's Executive Board concludes 132nd meeting

"The World Health Assembly's rotating Executive Board meets twice a year, and on 29 January concluded its 132nd meeting with what the WHO director general termed an 'unprecedented' amount of agenda items and documents," Intellectual Property Watch reports.

31 Jan 2013

CKD may raise risk of mortality and end stage renal disease for both men and women

A new study from the Johns Hopkins Bloomberg School of Public Health and the Chronic Kidney Disease Prognosis Consortium (CKD-PC) found that in general chronic kidney disease is similarly associated with a higher risk of death and end stage renal disease for both women and men. The findings were released online in advance of publication in BMJ.

31 Jan 2013

Genentech announces positive results from GA101 plus chlorambucil Phase III study on CLL

Genentech, a member of the Roche Group, today announced positive results from Stage 1 of CLL11, a Phase III randomized study to investigate the efficacy and safety profile of the investigational medicine obinutuzumab (GA101) plus chlorambucil chemotherapy compared with chlorambucil alone in people with previously untreated chronic lymphocytic leukemia (CLL).

31 Jan 2013

NSU's College of Osteopathic Medicine receives approval for new medical specialty

Nova Southeastern University's College of Osteopathic Medicine (NSU-COM) received approval for a new medical specialty—correctional medicine—that was developed at the college in collaboration with the Florida Department of Corrections.

31 Jan 2013

Possible new direction for treatment of metabolic syndrome

Obesity might be a very modern problem, but a team of scientists from Taiwan and China is turning to the age-old principles of traditional Chinese medicine (TCM) to help fight it. Breaking research published in the Journal of Biomolecular Structure and Dynamics indicates a possible new direction for the treatment of metabolic syndrome.

31 Jan 2013

Supplementation with omega-3 fatty acids promotes effective immune system response

Supplementation with omega-3 fatty acids promotes effective immune system response and has ameliorating effects on chronic inflammation (a condition caused by an imbalanced immune system that can lead to multiple serious illnesses over time), according to the most recent study published by the National Center for Biotechnology Information on the effects of omega-3.

31 Jan 2013

Mount Sinai to initiate immunological therapy trial against chronic pulmonary sarcoidosis

Patients are currently being enrolled in the first clinical trial to investigate the efficacy of immunological therapy for chronic pulmonary sarcoidosis. The trial is being conducted by researchers at the Icahn School of Medicine at Mount Sinai.

31 Jan 2013

No proof of added benefit from aclidinium bromide in adults with COPD

The drug aclidinium bromide has been approved since October 2012 for widening the narrowed airways of adults with chronic-obstructive pulmonary disease (COPD). The German Institute for Quality and Efficiency in Health Care (IQWiG) has now examined the added benefit of the drug pursuant to the "Act on the Reform of the Market for Medicinal Products" (AMNOG).

31 Jan 2013

Mayo Clinic cardiologists offer simple tips to reduce risk of heart disease

February is American Heart Month, a perfect time to remind people that small steps can reduce their risk of heart disease, the No. 1 killer of men and women. Mayo Clinic cardiologists offer several simple tips to reduce the risk.

31 Jan 2013

Androgens could constitute an efficient treatment against multiple sclerosis

Testosterone and its derivatives could constitute an efficient treatment against myelin diseases such as multiple sclerosis, reveals a study by researchers from the Laboratoire d'Imagerie et de Neurosciences Cognitives, in collaboration in particular with the "Neuroprotection et Neurorégénération: Molécules Neuroactives de Petite Taille" unit.

30 Jan 2013

IL-13 protein could be the key to development of fibrosis in Crohn's disease

New research has shown that a protein, known as IL-13, could be the key to the development of fibrosis in Crohn's disease. This breakthrough could help to advance new medicines to treat people suffering with the disease.

30 Jan 2013

Pediatric migraine drugs show limited or no efficacy

There is limited evidence supporting the efficacy of trazodone and topiramate in the prevention of pediatric episodic migraine headaches, show results from a meta-analysis.

30 Jan 2013

Chronic News and Research

Innate lymphoid cells may be new therapeutic target in treating atopic dermatitis

Merck full-year 2012 worldwide sales decrease 2% to $47.3 billion

Resonance Health receives FDA marketing authorization for FerriScan R2-MRI device

Adults should consume less than 5 g of salt and at least 3,510 mg of potassium per day: WHO

Hypertensive pregnancies need rigorous follow up

New insight into eczema’s itch

Interferon retreatment of chronic hepatitis C may be harmful

State roundup: Ga. hospital fee bill nears passage

World Health Assembly's Executive Board concludes 132nd meeting

CKD may raise risk of mortality and end stage renal disease for both men and women

Genentech announces positive results from GA101 plus chlorambucil Phase III study on CLL

NSU's College of Osteopathic Medicine receives approval for new medical specialty

Possible new direction for treatment of metabolic syndrome

Supplementation with omega-3 fatty acids promotes effective immune system response

Mount Sinai to initiate immunological therapy trial against chronic pulmonary sarcoidosis

No proof of added benefit from aclidinium bromide in adults with COPD

Mayo Clinic cardiologists offer simple tips to reduce risk of heart disease

Androgens could constitute an efficient treatment against multiple sclerosis

IL-13 protein could be the key to development of fibrosis in Crohn's disease

Pediatric migraine drugs show limited or no efficacy

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News